4.0 Article

Early diagnosis of Alzheimer's disease on ADNI data using novel longitudinal score based on functional principal component analysis

期刊

JOURNAL OF MEDICAL IMAGING
卷 8, 期 2, 页码 -

出版社

SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
DOI: 10.1117/1.JMI.8.2.024502

关键词

Alzheimer's disease; dementia of the Alzheimer type; early prediction; longitudinal; functional principal component analysis; Alzheimer's disease neuroimaging initiative

资金

  1. National Science Engineering Research Council (NSERC)
  2. Canadian Institutes of Health Research (CIHR)
  3. Brain Canada Foundation
  4. Pacific Alzheimer's Research Foundation
  5. Michael Smith Foundation for Health Research (MSFHR)
  6. Alzheimer Society Research Program from Alzheimer Society of Canada
  7. Alzheimer Society of British Columbia
  8. Canadian Institute on Aging
  9. DOD ADNI (Department of Defense) [W81XWH-12-20012]
  10. National Institute on Aging
  11. National Institute of Biomedical Imaging and Bioengineering
  12. Alzheimer's Association
  13. Alzheimer's Drug Discovery Foundation
  14. Araclon Biotech
  15. Biogen
  16. Bristol-Myers Squibb Company
  17. CereSpir, Inc.
  18. Cogstate
  19. Elan Pharmaceuticals, Inc.
  20. Eli Lilly and Company
  21. EuroImmun
  22. F. Hoffmann-La Roche Ltd
  23. Canadian Institutes of Health Research
  24. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  25. AbbVie
  26. BioClinica, Inc.
  27. Eisai Inc.

向作者/读者索取更多资源

This study aimed to predict the onset of AD for mild cognitive impaired patients two years ahead using MRI-derived information. The results showed significantly improved predictive power using longitudinal FPC features compared to training using baseline volume, demonstrating the advantage of using FPC-derived longitudinal features for predicting disease onset.
Methods: Alzheimer's disease (AD) is a worldwide prevalent age-related neurodegenerative disease with no available cure yet. Early prognosis is therefore crucial for planning proper clinical intervention. It is especially true for people diagnosed with mild cognitive impairment, to whom the prediction of whether and when the future disease onset would happen is particularly valuable. However, such prognostic prediction has been proven to be challenging, and previous studies have only achieved limited success. Approach: In this study, we seek to extract the principal component of the longitudinal disease progression trajectory in the early stage of AD, measured as the magnetic resonance imaging (MRI)-derived structural volume, to predict the onset of AD for mild cognitive impaired patients two years ahead. Results: Cross-validation results of LASSO regression using the longitudinal functional principal component (FPC) features show significant improved predictive power compared to training using the baseline volume 12 months before AD conversion [area under the receiver operating characteristic curve (AUC) of 0.802 versus 0.732] and 24 months before AD conversion (AUC of 0.816 versus 0.717). Conclusions: We present a framework using the FPCA to extract features from MRI-derived information collected from multiple timepoints. The results of our study demonstrate the advantageous predictive power of the population-based longitudinal features to predict the disease onset compared with using only cross-sectional data-based on volumetric features extracted from a single timepoint, demonstrating the improved prediction power using FPC-derived longitudinal features. (C) 2021 Society of Photo-Optical Instrumentation Engineers (SPIE)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据